Ready for Clinical Trials in 1 Hour: A Roadmap to Success
Jonathan Mulpas, Will Ganley and Carolina Dantas
The Transition To Low GWP Propellants In pMDIs: Increasing Your Probability of Success Using a Collaborative Approach
Ross Errington and Ameet Sule
Biologics for Nebulization: An Approach to Formulation and Manufacture
Alan Watts and Jean-Francois Boe
Unlock the Mysteries of APSD Data Analysis: Transform your Inhaled Product Development
Clair Brooks and Matthew Fenn
Navigating the Global Regulatory Landscape Enabling the Sustainability Transition in the pMDI Space
Mark Boelens, Andrew Van Deusen, Nilesh Wagh and Michiel Ullmann
Optimizing Biologics Powder Formulations: Achieving High Drug Load, Stability, and Efficient Inhalation
Luis Marques and Filipe Vultos
A Systematic and Efficient Approach Through Use of Complimentary Expertise to Mitigate Uncertainty and Accelerate Dry Powder Inhaler Development
Irene Rossi, Ross Blezard and Andrea Silvestri
Fast Tracking Complex Delivery Systems: From Targeted Nasal Delivery to High Dose Lung Delivery
Adrian Raiche and Keith Ung
An Expanded Toolbox for Respirable Dry Powders: Pulmonary and Intranasal Delivery for Small and Biotherapeutic APIs
Beatriz Noriega Fernandes and Eric Peterson
Technical Challenges in Sustaining Medical Propellant Supply During The Low GWP Transition
Paul Watkinson and Darren Bromley-Davenport
From Botanicals to Biologics: Matching the Molecule with a Delivery Platform and Formulation Approach
Sandy Munro, Charlie Schumacher, Phil Swanbury and Geraldine Venthoye
Emerging Role of Nasal Casts and Automation for the In Vitro Evaluation of Nasal Drug Products
Grant Thurston and Ben Okorodudu
